The Current Ratio as of December 2025 (TTM) for Genovate Biotechnology Co., Ltd. (4130.TWO) is 5.60

According to Genovate Biotechnology Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 5.60. This represents a change of 2.15% compared to the average of 5.48 of the last 4 quarters.

Genovate Biotechnology Co., Ltd. (4130.TWO) Historical Current Ratio (quarterly & annually)

How has 4130.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Genovate Biotechnology Co., Ltd. over the last ten years is 4.88. The current 5.60 Current Ratio has changed 11.38% with respect to the historical average. Over the past ten years (40 quarters), 4130.TWO's Current Ratio was at its highest in in the December 2023 quarter at 6.56. The Current Ratio was at its lowest in in the March 2025 quarter at 4.78.

Genovate Biotechnology Co., Ltd. (4130.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Genovate Biotechnology Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genovate Biotechnology Co., Ltd. (4130.TWO) Average Current Ratio

How has 4130.TWO Current Ratio performed in the past?

The current Current Ratio of Genovate Biotechnology Co., Ltd. (4130.TWO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Genovate Biotechnology Co., Ltd. (4130.TWO) Current Ratio vs. Peers

How is 4130.TWO’s Current Ratio compared to its peers?

Genovate Biotechnology Co., Ltd.’s Current Ratio is greater than Golden Biotechnology Corporation (0.54), greater than Diamond Biotechnology Co., Ltd (3.55), greater than Shangya Technology Co., Ltd. (3.05), less than Applied BioCode Corporation (9.54), greater than Winston Medical Supply Co., Ltd. (1.60), less than Hcmed (11.14), greater than TSH Biopharm Corporation Limited (4.94), greater than InnoCare Optoelectronics Corporation (2.38), greater than Wellell Inc. (2.41), less than LIWANLI Innovation Co., Ltd. (13.30),

Build a custom stock screener for Genovate Biotechnology Co., Ltd. (4130.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genovate Biotechnology Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genovate Biotechnology Co., Ltd. (4130.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genovate Biotechnology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.